Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine.

Drago, F; Ciccarese, G; Guadagno, A; Parodi, A

Drago, F; Ciccarese, G; Guadagno, A; Parodi, A.

Drago F; Dermatology Unit, Ospedale Policlinico San Martino, Genoa, Italy.
Ciccarese G; Dermatology Unit, Ospedale Policlinico San Martino, Genoa, Italy.
Guadagno A; Pathology Unit, Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Parodi A; Dermatology Unit, Ospedale Policlinico San Martino, Genoa, Italy.

J Eur Acad Dermatol Venereol ; 36(12): e979-e981, 2022 12.

Article in English | MEDLINE | ID: covidwho-1937950

Subject(s)

COVID-19; Pityriasis Lichenoides; Vaccines; Humans; COVID-19 Vaccines/adverse effects; BNT162 Vaccine; COVID-19/prevention & control; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Pityriasis Lichenoides / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18418

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google